Aris Polyzos
Impact in
- Oncology top 5%
- Colorectal Cancer Treatments and Studies
- Pancreatic and Hepatic Oncology Research
- Lung Cancer Research Studies
- Cancer Treatment and Pharmacology
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Oncology 24
- Colorectal Cancer Treatments and Studies 8
- Cancer Treatment and Pharmacology 6
- Pancreatic and Hepatic Oncology Research 6
- Lung Cancer Research Studies 5
-
- Lung Cancer Treatments and Mutations 10
- Gastric Cancer Management and Outcomes 3
- Co-authors
- Vassilis Georgoulias (15 shared papers)George Samonis (6 shared papers)Nikolaos Ziras (9 shared papers)Stylianos Kakolyris (5 shared papers)Konstantinos N. Syrigos (2 shared papers)Ch. Kouroussis (3 shared papers)John Souglakos (6 shared papers)Nikolaos E. M. Androulakis (8 shared papers)
- Journals
- Oncology (6 papers)Cancer Chemotherapy and Pharmacology (5 papers)Lung Cancer (4 papers)British Journal of Cancer (3 papers)Journal of Chemotherapy (2 papers)
- Partner nations
- GreeceUnited StatesChina
In The Last Decade
Aris Polyzos
51 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 74
- Oncology 979
- Hepatology 145
- Cancer Research 176
- Pulmonary and Respiratory Medicine 382
- Surgery 228
Countries citing papers authored by Aris Polyzos
This map shows the geographic impact of Aris Polyzos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aris Polyzos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aris Polyzos more than expected).
Fields of papers citing papers by Aris Polyzos
This network shows the impact of papers produced by Aris Polyzos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aris Polyzos. The network helps show where Aris Polyzos may publish in the future.
Co-authors
The 25 scholars most cited alongside Aris Polyzos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 314 | |
| 2 | 2006 | 175 | |
| 3 | 2005 | 144 | |
| 4 | Predictors of survival in stage IV metastatic colorectal cancer. | 2010 | 94 |
| 5 | 2004 | 88 | |
| 6 | VIPomas: an update in diagnosis and management in a series of 11 patients. | 2005 | 68 |
| 7 | Liposomal doxorubicin in conjunction with reirradiation and local hyperthermia treatment in recurrent breast cancer: a phase I/II trial. | 2002 | 67 |
| 8 | 2012 | 56 | |
| 9 | Prognostic factors in patients with locally advanced (unresectable) or metastatic pancreatic adenocarcinoma: a retrospective analysis. | 2008 | 46 |
| 10 | 2006 | 40 | |
| 11 | 2007 | 38 | |
| 12 | The clinical significance of serum markers of bone turnover in NSCLC patients: surveillance, management and prognostic implications. | 2009 | 32 |
| 13 | 2009 | 27 | |
| 14 | 2003 | 26 | |
| 15 | 2004 | 25 | |
| 16 | 2008 | 24 | |
| 17 | 2010 | 24 | |
| 18 | 2006 | 20 | |
| 19 | Clostridium difficile is emerging in Romania: a story of 027 ribotype and excessive antibiotic consumption. | 2014 | 20 |
| 20 | Tolerability of adjuvant high-dose interferon alfa-2b: 1 month versus 1 year--a Hellenic Cooperative Oncology Group study. | 2004 | 19 |
About Aris Polyzos
Aris Polyzos is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Epidemiology and Pathology and Forensic Medicine, having authored 51 papers that have together received 1.6k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (10 papers), Colorectal Cancer Treatments and Studies (8 papers), Cancer Treatment and Pharmacology (6 papers), Neuroendocrine Tumor Research Advances (6 papers), Pancreatic and Hepatic Oncology Research (6 papers), Lung Cancer Research Studies (5 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers) and Gastric Cancer Management and Outcomes (3 papers). The work is most often cited by research in Oncology (979 citations), Hepatology (145 citations), Cancer Research (176 citations), Pulmonary and Respiratory Medicine (382 citations) and Surgery (228 citations). Aris Polyzos has collaborated with scholars based in Greece, United States and China. Frequent co-authors include Vassilis Georgoulias, George Samonis, Nikolaos Ziras, Stylianos Kakolyris, Konstantinos N. Syrigos, Ch. Kouroussis, John Souglakos, Nikolaos E. M. Androulakis, L. Vamvakas and D. Mavroudis. Their work appears in journals such as Oncology, Cancer Chemotherapy and Pharmacology, Lung Cancer, British Journal of Cancer and Journal of Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.